OhioHealth | Jotup

InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024

Retrieved on:

星期二, 五月 28, 2024

TEL AVIV, Israel, and MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the presentation of positive one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Carotid Stent System for the treatment of carotid artery stenosis at this year’s Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.

Key Points:

Marvin Slosman, chief executive officer of InspireMD, stated, “We are very pleased to have such a significant presence at this year’s LINC conference, highlighted by a presentation of the primary endpoint results from our C-GUARDIANS clinical study.
The independently adjudicated major adverse event rates through one-year are the lowest reported to date from any carotid stent or embolic protection device pivotal trial.
These data confirm the potential ‘neuroprotective properties’ of this unique MicroNet technology, offering an outstanding front-line option to consider for each patient with obstructive carotid artery disease."
The presentation is available on our website at: Clinical Presentations - InspireMD

Park National Corporation welcomes Kelly Gratz and Karen Morrison to Board of Directors

Retrieved on:

星期二, 五月 21, 2024

NEWARK, Ohio, May 21, 2024 (GLOBE NEWSWIRE) -- Park National Corporation’s (NYSE American: PRK) (Park) board of directors announced today that they elected Karen Morrison and Kelly Gratz to serve as directors effective July 1, 2024.

Key Points:

NEWARK, Ohio, May 21, 2024 (GLOBE NEWSWIRE) -- Park National Corporation’s (NYSE American: PRK) (Park) board of directors announced today that they elected Karen Morrison and Kelly Gratz to serve as directors effective July 1, 2024.
Both will also join the board of directors of The Park National Bank, Park’s banking subsidiary, effective on the same date.
“Karen and Kelly bring wisdom and a variety of experiences to Park,” said Park Chair and Chief Executive Officer David Trautman.
“I am thrilled to join Park’s board of directors, it is a profound honor,” said Gratz.

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

Retrieved on:

星期二, 三月 26, 2024

Neuroprotection, OhioHealth, VIVA, LINC, EPS, Stroke, NSPR, Carotid artery stenosis, Clinical trial, PMA, ITT, TEL

TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.

Key Points:

TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.
Chris Metzger, M.D., System Vascular Chief at Ohio Health, and lead investigator of the C-Guardians trial
Marvin Slosman, chief executive officer of InspireMD, stated, “At last year’s VIVA and VEITH conferences in November, Dr. Metzger, principal investigator for the C-GUARDIANS trial, presented positive 30-day follow-up data from the trial which demonstrated a DSMI1 rate of just 0.95% in the Intent-To-Treat (ITT) analysis population, and 0.63% in the per-protocol (PP) analysis population.
We are very excited to announce today that an abstract of the 12-month outcomes data from this important trial has been accepted for presentation at the upcoming LINC 2024 conference, which is among the most influential and widely attended meetings focused on vascular intervention.
We are optimistic that the results will show a similar level of neuroprotection, which may support a Premarket Approval Application (PMA) later this year and allow us to prepare for a commercial launch of CGuard Prime in the U.S. in the first half of 2025, if approved.”

Safe House Project Revolutionizes Fight Against Human Trafficking in the United States Through Innovative Programs and Collaborative Partnerships

Retrieved on:

星期五, 三月 29, 2024

Statistics, Freedom, OhioHealth, Risk, Education, Child, Atrium Health, Continuing medical education, CME, Survivor, Housing, Justice, Crime, Novant Health, Former, Victim, Ascension (healthcare system), Drug

WASHINGTON, March 29, 2024 /PRNewswire/ -- In a transformative approach to combating human trafficking in the United States, Safe House Project is revolutionizing the fight against this pervasive crime.

Key Points:

WASHINGTON, March 29, 2024 /PRNewswire/ -- In a transformative approach to combating human trafficking in the United States, Safe House Project is revolutionizing the fight against this pervasive crime.
This critical work also addresses the urgent need for safe housing and quality care, key factors in preventing the re-trafficking of survivors.
Safe House Project, serving as the national certifying agency for programs offering residential services to trafficking victims, is pivotal in changing these statistics.
Major healthcare networks like Novant Health, Ohio Health, Atrium Health, and Ascension Health are collaborating with Safe House Project to develop processes for responding to human trafficking effectively.

Jill Schwieters Honored with Prestigious Baldrige Foundation's Leadership Award for Health Care Excellence

Retrieved on:

星期二, 三月 19, 2024

Health, Biography, Baldrige, Patient, Senior, OhioHealth, Courage, Nursing

CHICAGO, March 19, 2024 /PRNewswire/ -- The Foundation for the Malcolm Baldrige National Quality Award, Inc. has announced Jill Schwieters, a distinguished healthcare executive and entrepreneur, as one of the recipients of the prestigious Baldrige Foundation's Leadership Award for Health Care Excellence.

Key Points:

CHICAGO, March 19, 2024 /PRNewswire/ -- The Foundation for the Malcolm Baldrige National Quality Award, Inc. has announced Jill Schwieters, a distinguished healthcare executive and entrepreneur, as one of the recipients of the prestigious Baldrige Foundation's Leadership Award for Health Care Excellence.
This recognition celebrates Schwieters' outstanding contributions to the healthcare industry and her exemplary leadership in driving innovation and excellence.
As a seasoned healthcare executive and visionary entrepreneur, Jill Schwieters demonstrates exceptional leadership, setting an example for executives and entrepreneurs in healthcare.
Her transformative and innovative approach pushes the boundaries in healthcare, making her a well-deserving recipient of the prestigious Baldrige Foundation's Leadership Award."

Greif Announces New Partnership with the Columbus Blue Jackets NHL Franchise

Retrieved on:

星期五, 二月 2, 2024

Partnership, Growth, Curriculum, OhioHealth, Obesity, Blue, Literacy, Safety, Blue Jacket, Ice, Corporation, Columbus Blue Jackets, Health, Hockey, Education, NHL, Organization, Drug

DELAWARE, Ohio, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, is excited to announce a new corporate partnership with the Columbus Blue Jackets National Hockey League (NHL) franchise through 2026.

Key Points:

DELAWARE, Ohio, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, is excited to announce a new corporate partnership with the Columbus Blue Jackets National Hockey League (NHL) franchise through 2026.
The partnership includes a new fundraising platform for the Blue Jackets Foundation, supporting their community initiatives, and contributing to the team’s hockey-themed wellness curriculum.
After years as terrace ticket holders, we believed it was time to elevate our partnership with the Columbus Blue Jackets, providing an opportunity to engage with the community through impactful initiatives,” said Crystal Cassady, Public Relations at Greif.
The partnership also includes support for the Blue Jacket’s Power Play Challenge program, which is a free, hockey-themed wellness curriculum designed to combat childhood obesity.

Caregility Helps Transform Inpatient Care with New AI-Enhanced Telehealth Systems

Retrieved on:

星期四, 一月 11, 2024

In a significant leap forward for inpatient care, Caregility is proud to introduce a new class of adaptive telehealth edge devices designed to seamlessly support hybrid care models that bring remote clinicians and artificial intelligence (AI) capabilities into bedside workflows at the point of care.

Key Points:

In a significant leap forward for inpatient care, Caregility is proud to introduce a new class of adaptive telehealth edge devices designed to seamlessly support hybrid care models that bring remote clinicians and artificial intelligence (AI) capabilities into bedside workflows at the point of care.
The devices integrate with the award-winning Caregility Cloud™ virtual care platform to enable a multitude of clinical applications.
The AI-enhanced telehealth edge devices facilitate seamless virtual clinical interactions, enhancing the efficiency and quality of patient care and clinical team collaboration.
Every Caregility device is self-healing, proactively monitored, and remotely managed to ensure reliability and minimize disruption to patient care.

Hippocratic AI Launches Early Access Partnership Program With Leading Healthcare Organizations Including OhioHealth, Roper St. Francis Healthcare, Evernow, HarmonyCares, and Guidehealth

Retrieved on:

星期五, 十二月 1, 2023

Workforce, Vocabulary, Health, Learning, Risk, OhioHealth, Caregiver, Physician, Woman, Hippocrates, CMO, Hospital, Education, LLM, PALO, Patient, Entrepreneurship, Safety, Nursing

The program will include leading health systems and digital health companies, including OhioHealth, Roper St. Francis Healthcare, Evernow, HarmonyCares, and Guidehealth, among many others.

Key Points:

The program will include leading health systems and digital health companies, including OhioHealth, Roper St. Francis Healthcare, Evernow, HarmonyCares, and Guidehealth, among many others.
“We believe generative AI holds incredible potential to advance on the promise of technology to deliver meaningful transformation and efficiency for our caregivers and our patients.
“I’m excited about exploring our options for patient care with Hippocratic AI,” said Michael Millie, MD, CMO at HarmonyCares.
That's why collaboration is so fundamental to everything we do,” said Meenesh Bhimani MD, Co-Founder & Chief Medical Officer of Hippocratic AI.

Dr. John Parker Joins PeriGen as Chief Medical Officer, Bringing Expertise to Advance Maternal and Infant Healthcare

Retrieved on:

星期三, 十一月 29, 2023

OhioHealth, Health, Obstetrics, Perigenes, Workflow, Research, Riverside Methodist Hospital, Gynaecology, FDA

CARY, N.C., Nov. 29, 2023 /PRNewswire/ -- PeriGen Inc, the market leader in FDA-cleared AI-based maternal-fetal early warning systems today announced the addition of John Parker, M.D., as the company's new Chief Medical Officer.

Key Points:

CARY, N.C., Nov. 29, 2023 /PRNewswire/ -- PeriGen Inc, the market leader in FDA-cleared AI-based maternal-fetal early warning systems today announced the addition of John Parker, M.D., as the company's new Chief Medical Officer.
Dr. Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research.
Parker started his career in software development, serving as a developer, designer, sales support engineer, and consultant before deciding to pursue medicine.
"He is exceptional at helping PeriGen clients understand how to best leverage PeriGen analytics within their workflow."

Hammes Healthcare and OhioHealth break ground on new Women's Center at Riverside Methodist Hospital

Retrieved on:

星期二, 十一月 21, 2023

Woman, Methodist Hospital, Hammes, OhioHealth, Riverside Methodist Hospital, Grant, Health care, Female, Hospital, Nursing

MILWAUKEE, Nov. 21, 2023 /PRNewswire-PRWeb/ -- Hammes Healthcare, a leading provider of consulting and project delivery services, will be serving as OhioHealth's project manager for the new Women's Center that broke ground last month.

Key Points:

Hammes Healthcare will be serving as OhioHealth's project manager for the new Women's Center that broke ground last month.
The new OhioHealth Women's Center will be a standalone facility located on the OhioHealth Riverside Methodist Hospital campus in Columbus, Ohio.
The new OhioHealth Women's Center will be a standalone facility located on the OhioHealth Riverside Methodist Hospital campus in Columbus, Ohio.
Hammes is also serving as owner's representative for the new OhioHealth Trauma and Critical Care Center at Grant and the new OhioHealth Pickerington Methodist Hospital.